Acupuncture Treatment is Associated with a Decreased Risk of Dementia in Patients with Depression: A Propensity Score-Matched Cohort Study.

BACKGROUND: Depression is one of the most disabling disorders, which causes long-term complications such as neurodegenerative disorder and cerebrovascular disease. Some patients with depression seek acupuncture treatment. We aimed to investigate the association between acupuncture treatment and the risk of dementia in patients with depression from the perspective of real-world evidence.
METHODS: Patients over 18 years old and newly diagnosed with depression between 1997 and 2010 were selected from the Taiwanese National Health Insurance Research Database and followed up until the end of 2013. Propensity score was used to match equal numbers of patients 1:1 (N = 16,609 per group) into acupuncture and non-acupuncture cohorts based on characteristics including sex, age, baseline comorbidity and drug use. The outcome measurement was the comparison of dementia incidence in the two cohorts.
RESULTS: Compared with the non-acupuncture cohort, patients who received acupuncture treatment had a decreased risk of dementia (adjusted hazard ratio (aHR) = 0.54; 95% confidence interval (CI) = 0.50-0.58, P < 0.001) after adjustment for age, sex, comorbidities and drug use. Compared with depression patients who did not receive acupuncture, the aHR of vascular dementia and Alzheimer's disease incidences for patients who had acupuncture therapy was 0.59 (95% CI 0.48-0.71) and 0.51 (95% CI 0.39-0.67), respectively. The cumulative incidence of dementia was significantly lower in the acupuncture cohort than in the non-acupuncture cohort (Log rank test, p < 0.001).
CONCLUSION: The present study from real-world data revealed that acupuncture reduced the risk of dementia in depression patients, which supports healthcare decisions in clinical practice.

Introduction

Depression, also called major depressive disorder (MDD), is a condition characterized by a gloomy (depressed) mood or anhedonia, which means a loss of interest in usually pleasurable activities. The DSM-5 criteria for major depressive disorder (MDD) include the presence of either of those symptoms for at least two weeks, plus four or more following symptoms: low energy or fatigue, insomnia or hypersomnia, loss or increased appetite/weight, psychomotor retardation or agitation, poor concentration or indecisiveness, suicidal ideation, and pathological guilt or feelings of worthlessness.1,2 Depression is common among adults worldwide. The World Health Organization estimates that 350 million people globally have depressive episodes. The World Mental Health Survey conducted in 17 countries found that, on average, approximately 5% of people have had depressive episodes. Moreover, approximately 1 million people with depression lose their lives due to suicide yearly, which means 3000 suicide deaths per day.3

Dementia is one of the major causes of disability in old age. It is a condition that is characterized by a decrease in cognition involving one or more cognitive domains (learning and memory, language, executive function, complex attention, perceptual-motor function, social cognition)2,4 As of 2010, there were 35.6 million people with dementia worldwide. The number is predicted to reach 65.7 million in 2030 and 115.4 million in 2050.5 Dementia mainly affects older people, and its prevalence increases exponentially with age. Depression and dementia commonly occur together in elderly people. Recent studies indicate that early-life depression could be a risk factor for later dementia and that later-life depression is a prodrome of dementia.6 These findings show the importance of effective treatment for depression, which may reduce the prevalence of dementia.

The most common standard initial therapy for depression consists of psychotherapy and antidepressants such as SSRIs, MAOIs, TCAs, SNRIs, NDRIs, SARIs and NaSSAs.7 However, antidepressants may cause side effects such as weight gain, sedation, dry mouth, nausea, blurred vision, constipation, and tachycardia.8,9 Therefore, some patients who suffer from depression may seek complementary or alternative treatments. One American survey revealed that 34% of psychiatric outpatients with depression were using alternative therapies.10 Another survey showed that 20% of depressed Americans had used complementary and alternative medicine therapy, including acupuncture, for their depression.11 In addition, among people seeking acupuncture in the United Kingdom, psychological distress, including depression, was the second most common reason.12 Acupuncture is one of the most popular complementary therapies in Taiwan.13,14 Some previous studies have indicated the benefits of acupuncture for depression. Chan’s systematic review and meta-analysis indicated that acupuncture combined with antidepressants is effective against depression. The therapeutic efficacy of the combination was better than that of antidepressants alone.15 Similar results were also found in another systematic review and meta-analysis, which indicated that early treatment of primary depression using SSRIs combined with electroacupuncture therapy was more efficient than SSRIs alone and led to better and earlier control of depressive symptoms.16 Another systematic review and meta-analysis showed that the incidence of side effects of acupuncture intervention was significantly lower than that of antidepressants in depression patients.17 Recent research shows that acupuncture may also be safe for treating dementia and may enhance the positive effect of drugs on cognitive function, allowing dementia patients to go about their daily lives.18 However, none of them have shown the evidence regarding the effects of acupuncture on the progression to dementia in patients with depression.

Taiwan launched the National Health Insurance (NHI) program in 1995. This compulsory insurance program covers more than 99% of all residents in Taiwan, and it provides universal care to the people of Taiwan. The NHI program began reimbursing Western medical services in 1995 and traditional Chinese medicine (TCM) services in 1996. The NHI administration has established a National Health Insurance Research Database (NHIRD), which includes all claims data. These datasets provided real-world data with long-term follow-up information, reducing the potential for sampling bias.19 Our previous studies have also shown that acupuncture treatment is beneficial for patients with fibromyalgia,20,21 arthritis,22,23 and depression24 in the NHIRD. As recently noted, “real-world” data are not inferior to clinical trials and may provide useful information.25 Due to the shortage of existing long-term follow-up studies, our study aims to determine whether acupuncture can decrease the risk of progression to dementia in patients with depression by using a random sample of one million patients selected from the NHIRD.

Materials and Methods

Data Source

The data in this study are selected from the Taiwanese NHIRD (), which contains the registration files and original claims data for reimbursements, including demographic characteristics, diagnoses, clinical visits, hospitalizations, procedures, prescriptions, and the medical costs for reimbursement; this information is provided to scientists in Taiwan for research purposes. The NHI program covers TCM services, including Chinese herbal medicine, manipulative therapies and acupuncture. The diagnostic codes follow the format of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM).

Study Population and Variables

The flowchart for enrolling patients with depression and dementia is shown in Figure 1. A sample of one million randomly selected individuals from the NHIRD database was used in this study. Patients (n = 65,569) with diagnosed depression (ICD-9-CM code: 296.2–296.3, 300.4, 311) between January 1997 and December 2010 were included in this study and then followed up until the end of 2013. Next, we narrowed the selection to patients who were newly diagnosed with depression between 1997 and 2010 and had at least 2 claims during that period. We excluded 1840 individuals who were younger than 18 years of age or who had missing information such as date of birth or sex. In addition, we excluded 3343 individuals whose date of dementia diagnosis (ICD-9-CM: 290, 294.1, 331.0–331.2) was before the date of depression diagnosis. In all, after these exclusions, there were 49,993 patients with newly diagnosed depression and at least 2 claims during the period from 1997 to 2010. The remaining patients were divided into two groups: those who received acupuncture treatment (n =23,149) and those who did not (n=26,844). We defined the date of first acupuncture treatment after the date of the new depression diagnosis as the index date for the acupuncture group, and we randomly chose a date between the date of the new depression diagnosis and the endpoint as the index date for the control group. The acupuncture treatment (n =16,609) group and the control (n=16,609) group were matched 1:1 for propensity score by age (in 5-year bins), sex, index year, initial year of diagnosis of depression, all comorbidities, and all drugs used (oral steroids; nonsteroidal anti-inflammatory drugs (NSAIDs); statins; and selective serotonin reuptake inhibitors (SSRIs: escitalopram, fluvoxamine, sertraline), monoamine oxidase inhibitors (MAOIs: selegiline, isocarboxazid, tranylcypromine, phenelzine, moclobemide), tricyclic antidepressants (TCAs: amoxapine, desipramine, imipramine, doxepin, clomipramine, trimipramine) and other antidepressant drugs (serotonin–norepinephrine reuptake inhibitors, SNRIs: venlafaxine, duloxetine, milnacipran; norepinephrine–dopamine reuptake inhibitor, NDRI: bupropion; serotonin antagonist and reuptake inhibitor, SARI: mesyrel; noradrenergic and specific serotonergic antidepressant, NaSSA: mirtazapine)) (Figure 1).

Figure 1

Flow chart of the selection of patients with depression from the National Health Insurance Research Database (NHIRD) between 1997 and 2000 in Taiwan. After excluding the patients who did not meet the inclusion criteria and matching by propensity score, the acupuncture and non-acupuncture cohorts each contained an equal number of patients.

Ethical Considerations

The investigation was carried out in accordance with the latest version of the Declaration of Helsinki. The National Health Research Institutes encrypted all information that could be used to identify individuals or care providers before release; it is therefore impossible to identify any individuals or care providers in the database. The Research Ethics Committee of China Medical University and Hospital approved this study and waived the requirement for informed consent (CMUH104-REC2-115).

Availability of Data and Material

The datasets analyzed from NHIRD were provided by the National Health Insurance Administration and maintained by the National Health Research Institutes of Taiwan. The use of NHIRD is limited to research purposes only. Applicants must follow the Computer-Processed Personal Data Protection Law () and related regulations of the National Health Insurance Administration and National Health Research Institutes.

Statistical Analysis

We used SAS software, version 9.4 (SAS Institute Inc., Cary, NC, USA), to analyze the data from the NHIRD. Descriptive statistics were applied to determine the demographic characteristics, treatment modalities, and frequency of prescriptions for acupuncture. The diagnoses were coded according to the ICD-9-CM codes. Data missing the important information such as date of birth or sex were excluded. To present the overall structure of the study groups, we calculated the mean and standard deviation (SD) for age and the percentage for sex, comorbidity, drug use, and types of acupuncture. To evaluate the distribution differences between acupuncture and non-acupuncture users, we used Student’s t-test for continuous variables and the chi-squared test for categorical variables. The Cox proportional hazard regression model was applied to estimate the hazard ratio (HR) and 95% confidence interval (CI) of dementia in patients with depression who received acupuncture compared with non-acupuncture users. We also used the Kaplan-Meier method and the Log rank test to estimate the cumulative risk of dementia with depression between acupuncture users and non-acupuncture users.

Results

After propensity score-matching by age (per 5 years), sex, index year, initial year of diagnosis of depression, all comorbidities, and drugs used (oral steroids; NSAIDs; statins; and SSRIs, MAOIs, TCAs and other antidepressant drugs), the acupuncture users (n=16,609) and non-acupuncture users (n=16,609) had similar demographic characteristics. Most acupuncture users received manual acupuncture (87.14%), while some received electroacupuncture (2.97%) and others used a combination of manual acupuncture and electroacupuncture (9.89%) (Table 1).

Table 1

Characteristics of Depression Patients According to Whether They Received Acupuncture

Variable	Accepted Acupuncture				p-value*
	No (n =16,609)		Yes (n =16,609)
	n	%	n	%
Sex					0.9188
Women	10,349	62.31	10,358	62.36
Men	6260	37.69	6251	37.64
Age group					0.99
18–39	6520	39.26	6520	39.26
40–59	7693	46.32	7693	46.32
≥60	2396	14.43	2396	14.43
Mean±SD (years)†	45.92(15.88)		45.93(15.85)		0.9746
Baseline comorbidity
Diabetes mellitus	2613	15.73	2714	16.34	0.131
Hypertension	5125	30.86	5125	30.86	0.99
Hyperlipidemia	4076	24.54	3993	24.04	0.2883
Congestive heart failure	413	2.49	413	2.49	0.99
Anxiety	166	1	168	1.01	0.9124
Alcoholism	296	1.78	284	1.71	0.6152
Tobacco use	132	0.79	130	0.78	0.9013
Obesity	160	0.96	148	0.89	0.4921
Drugs used
Oral steroids	13,069	78.69	13,052	78.58	0.82
NSAIDs	16,490	99.28	16,497	99.33	0.644
Statins	4144	24.95	4144	24.95	0.99
SSRIs	10,354	62.34	10,317	62.12	0.6754
MAOIs	1341	8.07	1349	8.12	0.8722
TCAs	6225	37.48	6225	37.48	0.99
Other antidepressant drugs	5512	33.19	5496	33.09	0.8521
Types of acupuncture
Manual acupuncture	–	–	14,473	87.14
Electroacupuncture	–	–	494	2.97
Combination of manual acupuncture and electroacupuncture	–	–	1642	9.89
Duration between depression date and index date, days (mean, median)	1405.73(1115)		1398.74(1077)

Notes: *Chi-squared test; †t-test.

Compared with depression patients who did not receive acupuncture treatment, the adjusted hazard ratio for dementia in patients who received acupuncture therapy was 0.54 (95% CI, (0.50–0.58), P < 0.001) (Table 2). The age-stratified results demonstrated that the risk of dementia increased with age. Depression patients over 60 years old had the highest risk of dementia (aHR, 26.51; 95% CI, (21.39–32.86), P < 0.001). Regarding comorbidities before the initial diagnosis date of depression, there was no significant relationship between the risk of dementia and anxiety, tobacco use or obesity. However, there was a significant relationship between the risk of dementia and comorbidities such as diabetes mellitus, hypertension, hyperlipidemia, congestive heart failure, and alcoholism. Depression patients with these comorbidities had an elevated risk of dementia (Table 2).

Table 2

Cox Model with Hazard Ratios and 95% Confidence Intervals of Dementia Associated with Acupuncture and Covariates Among Depression Patients

Variable	No. of Events (n=2507)	Crude*			Adjusted†
		HR	(95% CI)	p-value	HR	(95% CI)	p-value
Received acupuncture
No	1436	1.00	Reference		1.00	Reference
Yes	1071	0.63	(0.58–0.68)	<0.0001	0.54	(0.5–0.58)	<0.0001
Sex
Women	1557	1.00	Reference		1.00	Reference
Men	950	0.97	(0.89–1.05)	0.4437	0.98	(0.9–1.06)	0.5538
Age group
18–39	106	1.00	Reference		1.00	Reference
40–59	959	7.38	(6.04–9.02)	<0.0001	6.24	(5.08–7.67)	<0.0001
≥60	1442	41.87	(34.37–51)	<0.0001	26.51	(21.39–32.86)	<0.0001
Baseline comorbidity (ref=no comorbidity)
Diabetes mellitus	902	3.14	(2.9–3.41)	<0.0001	1.39	(1.27–1.52)	<0.0001
Hypertension	1746	5.43	(4.99–5.91)	<0.0001	1.86	(1.68–2.05)	<0.0001
Hyperlipidemia	1142	2.84	(2.63–3.08)	<0.0001	1.30	(1.19–1.42)	<0.0001
Congestive heart failure	190	4.02	(3.47–4.66)	<0.0001	1.19	(1.02–1.39)	0.0254
Anxiety	53	2.34	(1.79–3.08)	<0.0001	1.04	(0.79–1.37)	0.7531
Alcoholism	26	0.65	(0.44–0.96)	0.0294	1.51	(1.02–2.22)	0.04
Tobacco use	9	0.65	(0.34–1.25)	0.2007	0.82	(0.42–1.58)	0.5512
Obesity	12	0.62	(0.35–1.1)	0.1021	0.65	(0.37–1.14)	0.1337
Drugs used
Oral steroids	1887	0.72	(0.65–0.78)	<0.0001	0.53	(0.48–0.58)	<0.0001
NSAIDs	2452	0.17	(0.13–0.22)	<0.0001	0.2	(0.15–0.27)	<0.0001
Statins	812	1.32	(1.21–1.43)	<0.0001	0.56	(0.51–0.61)	<0.0001
SSRIs	1398	0.79	(0.73–0.85)	<0.0001	1.09	(1.01–1.18)	0.0354
MAOIs	360	1.65	(1.48–1.85)	<0.0001	1.47	(1.32–1.65)	<0.0001
TCAs	1291	1.61	(1.49–1.74)	<0.0001	1.1	(1.01–1.19)	0.0227
Other antidepressant drugs	531	0.57	(0.51–0.62)	<0.0001	0.71	(0.64–0.78)	<0.0001

Notes: Crude HR* represents relative hazard ratio. Adjusted HR† represents adjusted hazard ratio: adjusted for acupuncture; age; sex; diabetes mellitus; hypertension; hyperlipidemia; congestive heart failure; anxiety; alcoholism; tobacco use; obesity; oral steroids; NSAIDs; statins; and SSRIs, MAOIs, TCAs and other antidepressant drugs in Cox proportional hazards regression.

In addition, there was a significant relationship between the risk of dementia and whether drugs were used to treat depression after diagnosis. Compared to the group who did not use drugs, the patients who used SSRIs, MAOIs and TCAs had an elevated aHR (1.09, 1.47 and 1.1). This may be because patients who used these antidepressants initially had more severe depression than those who did not take them. However, the patients who used oral steroids, NSAIDs, statins and other antidepressant drugs had reduced aHRs (0.53, 0.20, 0.56 and 0.71).

In this study, 1071 patients in the acupuncture cohort (12.11 per 1000 person-years) and 1436 patients in the non-acupuncture cohort (19.68 per 1000 person-years) developed dementia (Table 3). The beneficial effect of acupuncture on the incidence of dementia was noted in both female and male patients (female aHR, 0.53; 95% CI, 0.48–0.58; male aHR, 0.56; 95% CI, 0.49–0.63). Although the risk of dementia gradually increased with age, acupuncture significantly decreased the progression of dementia in all age groups. Acupuncture decreased the risk of dementia in patients with depression with and without comorbidities (diabetes mellitus, hypertension, hyperlipidemia, congestive heart failure, anxiety, alcoholism, tobacco use, and obesity). Regardless of whether patients took oral steroids; NSAIDs; statins; or SSRIs, MAOIs, TCAs and other antidepressant drugs, fewer patients in the acupuncture cohort than in the non-acupuncture cohort developed dementia.

Table 3

Incidence Rates, Hazard Ratios and Confidence Intervals of Dementia for Those Depression Patients Who Received Acupuncture and Those Who Did Not, Stratified by Sex, Age, Comorbidities and Drug Use

Variables	Accepted Acupuncture						Compared with Non-Acupuncture Users
	No			Yes			Crude HR	Adjusted HR†
	(n=16,609)			(n=16,609)
	Event	Person-Years	IR	Event	Person-Years	IR	(95% CI)	(95% CI)
Total	1436	72,967	19.68	1071	88,451	12.11	0.63(0.58–0.68)***	0.54(0.50–0.58)***
Sex
Women	907	44,834	20.23	650	53,965	12.04	0.6(0.54–0.67)***	0.53(0.48–0.58)***
Men	529	28,133	18.80	421	34,485	12.21	0.67(0.59–0.76)***	0.56(0.49–0.63)***
Age group
18–39	63	29,388	2.14	43	33,886	1.27	0.61(0.41–0.9)*	0.6(0.41–0.88)**
40–59	593	35,517	16.70	366	42,337	8.64	0.52(0.46–0.6)***	0.5(0.44–0.57)***
≥60	780	8062	96.76	662	12,228	54.14	0.58(0.52–0.65)***	0.56(0.51–0.63)***
Baseline comorbidity
Diabetes mellitus
No	947	62,974	15.04	658	74,125	8.88	0.6(0.54–0.66)***	0.54(0.49–0.59)***
Yes	489	9992	48.94	413	14,326	28.83	0.61(0.53–0.69)***	0.54(0.48–0.62)***
Hypertension
No	446	52,435	8.51	315	61,220	5.15	0.61(0.53–0.71)***	0.55(0.48–0.64)***
Yes	990	20,532	48.22	756	27,230	27.76	0.59(0.54–0.65)***	0.53(0.48–0.58)***
Hyperlipidemia
No	783	56,817	13.78	582	68,164	8.54	0.63(0.56–0.7)***	0.54(0.49–0.6)***
Yes	653	16,150	40.43	489	20,286	24.10	0.61(0.54–0.69)***	0.54(0.48–0.6)***
Congestive heart failure
No	1336	71,659	18.64	981	86,606	11.33	0.62(0.57–0.67)***	0.54(0.49–0.58)***
Yes	100	1308	76.48	90	1845	48.78	0.65(0.49–0.86)**	0.54(0.4–0.73)***
Anxiety
No	1406	72,367	19.43	1048	87,591	11.96	0.63(0.58–0.68)***	0.54(0.5–0.59)***
Yes	30	599	50.06	23	859	26.77	0.55(0.32–0.95)*	0.46(0.26–0.81)**
Alcoholism
No	1419	71,892	19.74	1062	86,990	12.21	0.63(0.58–0.68)***	0.54(0.5–0.59)***
Yes	17	1075	15.82	9	1461	6.16	0.41(0.18–0.93)*	0.36(0.15–0.86)*
Tobacco use
No	1430	72,565	19.71	1068	88,016	12.13	0.63(0.58–0.68)***	0.54(0.5–0.58)***
Yes	6	402	14.92	3	435	6.90	0.46(0.11–1.84)	0.65(0.12–3.43)
Obesity
No	1427	72,446	19.70	1068	87,761	12.17	0.63(0.58–0.68)***	0.54(0.5–0.59)***
Yes	9	520	17.30	3	690	4.35	0.25(0.07–0.93)*	0.16(0.03–0.8)*
Drugs used
Oral steroids
No	390	13,866	28.13	230	16,465	13.97	0.52(0.44–0.61)***	0.48(0.41–0.57)***
Yes	1046	59,101	17.70	841	71,985	11.68	0.66(0.6–0.72)***	0.56(0.51–0.62)***
NSAIDs
No	36	211	170.31	19	362	52.56	0.41(0.23–0.71)**	0.32(0.16–0.63)***
Yes	1400	72,755	19.24	1052	88,089	11.94	0.63(0.58–0.68)***	0.55(0.5–0.59)***
Statins
No	983	53,146	18.50	712	64,936	10.96	0.61(0.55–0.67)***	0.51(0.46–0.56)***
Yes	453	19,821	22.85	359	23,514	15.27	0.67(0.58–0.77)***	0.61(0.53–0.7)***
SSRIs
No	633	27,835	22.74	476	34,418	13.83	0.63(0.56–0.71)***	0.54(0.48–0.61)***
Yes	803	45,132	17.79	595	54,032	11.01	0.62(0.56–0.69)***	0.53(0.48–0.59)***
MAOIs
No	1228	66,420	18.49	919	79,906	11.50	0.63(0.58–0.69)***	0.54(0.5–0.59)***
Yes	208	6546	31.77	152	8544	17.79	0.58(0.47–0.71)***	0.52(0.42–0.64)***
TCAs
No	714	44,222	16.15	502	52,576	9.55	0.61(0.54–0.68)***	0.51(0.45–0.57)***
Yes	722	28,745	25.12	569	35,875	15.86	0.64(0.57–0.71)***	0.57(0.51–0.63)***
Other antidepressant drugs
No	1147	49,042	23.39	829	60,722	13.65	0.60(0.55–0.66)***	0.53(0.48–0.58)***
Yes	289	23,925	12.08	242	27,728	8.73	0.71(0.6–0.85)***	0.57(0.47–0.67)***

Notes: Adjusted HR†: adjusted for acupuncture; age; sex; diabetes mellitus; hypertension; hyperlipidemia; congestive heart failure; anxiety; alcoholism; tobacco use; obesity; oral steroids; NSAIDs; statins; and SSRIs, MAOIs, TCAs and other antidepressant drugs in Cox proportional hazards regression. *p<0.05; **p<0.01; ***p<0.001.

Abbreviations: IR, incidence rate (per 1000 person-years); HR, hazard ratio; CI, confidence interval.

We also analyzed the incidence rates, hazard ratio and confidence intervals of vascular dementia (ICD-9-CM: 290.4) and Alzheimer’s disease (ICD-9-CM: 331.0) for depression patients who received acupuncture and those who did not. The acupuncture cohort had a reduced risk of vascular dementia and Alzheimer’s disease (Table 4). In this study, 193 patients in the acupuncture cohort (2.18 per 1000 person-years) and 226 patients in the non-acupuncture cohort (3.19 per 1000 person-years) developed vascular dementia. Compared with depression patients who did not receive acupuncture, the aHR of vascular dementia incidence for patients who had acupuncture therapy was 0.59 (95% CI 0.48–0.71). There were 96 patients in the acupuncture cohort (1.08 per 1000 person-years) and 126 patients in the non-acupuncture cohort (1.72 per 1000 person-years) who developed Alzheimer’s disease. Compared with depression patients who did not receive acupuncture, the aHR of Alzheimer’s disease incidence for patients who had acupuncture therapy was 0.51 (95% CI 0.39–0.67).

Table 4

Incidence Rates, Hazard Ratio and Confidence Intervals of Vascular Dementia (ICD-9-CM: 290.4) and Alzheimer’s Disease (ICD-9-CM: 331.0) for Those Depression Patients Who Received Acupuncture and Those Who Did Not, Stratified by Sex, Age, Comorbidities and Drug Use

Variables	Acupuncture						Compared with Non-Acupuncture Users
	No			Yes			Crude HR	Adjusted HR†
	(n=16,933)			(n=16,933)
	Event	Person-Years	IR	Event	Person-Years	IR	(95% CI)	(95% CI)
Vascular dementia	226	73,247	3.09	193	88,612	2.18	0.70(0.57–0.84)***	0.59(0.48–0.71)***
Alzheimer’s disease	126	73,210	1.72	96	88,559	1.08	0.61(0.47–0.80)***	0.51(0.39–0.67)***

Notes: Adjusted HR†: adjusted for acupuncture; age; sex; diabetes mellitus; hypertension; hyperlipidemia; congestive heart failure; anxiety; alcoholism; tobacco use; obesity; oral steroids; NSAIDs; statins; and SSRIs, MAOIs, TCAs and other antidepressant drugs in Cox proportional hazards regression. ***p<0.001.

Abbreviations: IR, incidence rate (per 1000 person-years); HR, hazard ratio; CI, confidence interval.

Figure 2 reveals the cumulative incidence of dementia. Overall, the results suggest that in patients with depression, the cumulative incidence of dementia was lower in acupuncture users than in non-acupuncture users during the follow-up period (Log rank test, P < 0.001).

Figure 2

Cumulative incidence of dementia between the acupuncture cohort and the non-acupuncture cohort. The cumulative incidence of dementia was significantly lower in the acupuncture cohort than in the non-acupuncture cohort (Log rank test, p < 0.0001).

Discussion

In this study, we provided some evidence, although not a clinical trial, from the “real-world” data demonstrating the association between the acupuncture treatments and the reduced risk of developing dementia in patients with depression. Our study has several strengths. The “real-world” data from the NHIRD provided large-scale cohort with long-term follow-up data.19 The current knowledge regarding the efficacy of clinical intervention is usually limited to clinical trials.25 None of the previous data regarding the utilization of acupuncture for depression are supported by large-scale “real-world” data. As all patients with depression were registered in the NHI program since 1995, we were able to use the database to perform this study. These datasets provide a nationwide population-based claim database with long-term follow-up data. Thus, this propensity-score matched data are highly reliable, reducing the potential for sampling and allocation bias.

As a popular alternative treatment for depression, acupuncture has been performed on patients with depression in several clinical trials. However, most previous studies have focused on the effectiveness and safety of acupuncture therapy in depressive disorders. In addition, current studies on the benefits of acupuncture for depression and dementia are limited. Systematic reviews have shown the disadvantages of recent clinical trials, such as small sample size, uncertain description of enrolment criteria, poor quality of randomization or blinding, and different forms of acupuncture. Our research showed that depression patients who received acupuncture had a lower risk of developing dementia than the non-acupuncture cohort. To the best of our knowledge, this is the first large-scale population-based cohort study to demonstrate a decreased dementia risk in depression patients receiving acupuncture therapy.

Acupuncture may be associated with a reduced risk of dementia in patients with depression for several reasons. Recent studies have presented some possible explanations for the benefits of acupuncture against dementia. In a series of studies using animal models of Alzheimer’s disease, electroacupuncture stimulation reduced mitochondrial damage and amyloid beta plaques in the hippocampal CA1 region and increased the levels of choline acetyltransferase (ChAT) in the brain, as well as the capacity for learning and memory.26–28 A previous mouse study found that acupuncture completely or partially reversed some aging-related changes in hippocampal gene expression profiles.29 Other mouse research also showed that acupuncture reduced cognitive deficits and neuronal loss in the hippocampal CA3 region and DG.30,31 In addition, a previous research indicated that electroacupuncture decreased Aβ protein expression and oxidative damage in the hippocampus of a rate model.32 Stem cell mobilization and progenitor cell proliferation in the central nervous system may also occur after acupuncture treatment for neurodegenerative diseases.31,33

A previous study using resting-state functional magnetic resonance imaging (RS-fMRI) found that acupuncture stimulation could modulate the activity of the default mode network in Alzheimer’s disease patients.34 Another fMRI study indicated that acupuncture could improve hippocampal connectivity in Alzheimer’s disease patients.35 It was also found that the right hemisphere (the temporal lobe, such as the hippocampal gyrus; the insula; and some areas of the parietal lobe) and left hemisphere (the temporal lobe, the parietal lobules, and some regions of the cerebellum) were activated after acupuncture therapy. The regions activated by acupuncture overlap with the areas of the brain that are impaired in Alzheimer’s disease patients.36

Alzheimer’s disease is the most common form of dementia in the elderly, accounting for 60–80% of cases.37 After Alzheimer’s disease, vascular dementia is the second most common form of dementia in most clinical series, accounting for 10–20% of cases in North America and Europe.38,39 In this study, we found that the acupuncture cohort with depression had a lower risk of vascular dementia and Alzheimer’s disease compared with depression patients who did not receive acupuncture. The common mechanism that acupuncture reduced the risk of both types of dementia still need further laboratory investigations.

It has to be point out that our research also has some limitations. First, the NHIRD did not provide data to measure the severity of depressive disorders. To minimize this confounding factor, we performed 1:1 propensity score matching to ensure that all the baseline characteristics of both cohorts (including the anti-depressants) were similar. Second, the lifestyles of the two cohorts could be different. The NHIRD did not provide data about patients’ lifestyles, such as smoking frequency, body mass index (BMI), stress, and exercise. Studies have indicated that many dementia cases are attributable to risk factors such as obesity, physical inactivity, and smoking.40 Since data on lifestyle factors were deficient, we had only a limited ability to study these personal habits and customs in connection with illness. We performed 1:1 propensity score matching including the diagnoses of tobacco use and obesity and found that the comorbidities of both cohorts were similar. However, the percentages of smoking and obesity were still underestimated in both cohorts. Third, patients who seek acupuncture may have an increased level of motivation to address depression. Although the co-pay of acupuncture therapy is low (5–7 USD per treatment) under the NHI program, it is still a burden for poor people to consult doctors frequently. Thus, acupuncture users may have greater financial ability to obtain tangible or intangible resources than non-users.

Conclusion

Patients who suffer from depression may utilize complementary therapies; in Taiwan, many patients choose acupuncture. Our study suggests that acupuncture treatment is associated with a reduced risk of dementia in patients with depression. We hope that additional clinical trials and research studies based on this study’s findings will be undertaken in the future. Further research is necessary to determine the mechanism behind the protective effect of acupuncture.